Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Stephan P. Babirak"'
Autor:
Mohamed Iydroose, Heather M. Minchew, Kelley C Dacus, Anne C. Goldberg, Linda C. Hemphill, Gerald Wilson, Patrick M. Moriarty, Richard L. Dunbar, Julie Ann Dutton, Michael Wooten, Stephan P. Babirak
Publikováno v:
Journal of clinical lipidology. 14(6)
Background The previously published ODYSSEY ESCAPE trial demonstrated a significant reduction in the use of lipoprotein apheresis for heterozygous familial hypercholesterolemia (HeFH) patients when placed on alirocumab 150 mg every 2 weeks. In patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df32af64a147425e0f4a6568e5cb8137
https://pubmed.ncbi.nlm.nih.gov/32978095
https://pubmed.ncbi.nlm.nih.gov/32978095
Autor:
Elisabeth Steinhagen-Thiessen, Paul D. Thompson, Yunling Du, Anja Vogt, V.J.J. Schettler, Klaus G. Parhofer, Wolfgang Ramlow, Bernd Hohenstein, Josef Leebmann, Marc-Andre Cornier, Stephan P. Babirak, Berndt von Stritzky, Patrick M. Moriarty, Vinaya Simha, Garen Manvelian, P. Barton Duell
Publikováno v:
European Heart Journal. 37:3588-3595
Aim To evaluate the effect of alirocumab on frequency of standard apheresis treatments [weekly or every 2 weeks (Q2W)] in heterozygous familial hypercholesterolaemia (HeFH). Methods and results ODYSSEY ESCAPE ([NCT02326220][1]) was a double-blind stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1585d56a6a21d99f6ff2adbc71d4337d
https://doi.org/10.1093/eurheartj/ehw388
https://doi.org/10.1093/eurheartj/ehw388
Autor:
P. Barton Duell, Wolfgang Ramlow, Patrick M. Moriarty, Yunling Du, Emil M. deGoma, Berndt von Stritzky, Vinaya Simha, Paul D. Thompson, Garen Manvelian, Bernd Hohenstein, Elisabeth Steinhagen-Thiessen, Anja Vogt, Klaus G. Parhofer, Stephan P. Babirak
Publikováno v:
Journal of Clinical Lipidology. 10:627-634
Background Many patients with heterozygous familial hypercholesterolemia (HeFH) fail to reach optimal low-density lipoprotein cholesterol (LDL-C) levels with available lipid-lowering medications, including statins, and require treatment using alterna
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfa135310de117824a512d30e9c65b36
https://doi.org/10.1016/j.jacl.2016.02.003
https://doi.org/10.1016/j.jacl.2016.02.003
Autor:
Anne C. Goldberg, Linda C. Hemphill, Stephan P. Babirak, Michael Wooten, Gerald Wilson, Patrick M. Moriarty, Richard L. Dunbar
Publikováno v:
Journal of Clinical Lipidology. 11:834-835
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::035832d57f75fd7c1640c1532e693fa2
https://doi.org/10.1016/j.jacl.2017.04.101
https://doi.org/10.1016/j.jacl.2017.04.101
Publikováno v:
The Journal of nutrition. 104(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::207ed7959d5c55835b27eeddddba215e
https://pubmed.ncbi.nlm.nih.gov/4816930
https://pubmed.ncbi.nlm.nih.gov/4816930